FDA approves expanded emergency use of remdesivir in moderate COVID-19 patients

BY

-

Sat, 29 Aug 2020 - 11:37 GMT

BY

Sat, 29 Aug 2020 - 11:37 GMT

A member of the medical staff shows a used sample container at a test centre for coronavirus disease COVID-19 at Havelhoehe community hospital in Berlin, Germany, April 6. REUTERS/Fabrizio Bensch -/File Photo

A member of the medical staff shows a used sample container at a test centre for coronavirus disease COVID-19 at Havelhoehe community hospital in Berlin, Germany, April 6. REUTERS/Fabrizio Bensch -/File Photo

Aug 28 (Reuters) - Gilead Inc said on Friday the U.S. Food and Drug Administration has authorized expanded emergency use for its experimental antiviral COVID-19 treatment, remdesivir.

The drug can now be used to treat all hospitalized patients with COVID-19, in addition to patients with a severe form of the illness.

Comments

0

Leave a Comment

Be Social